COMMUNIQUÉS West-GlobeNewswire

MyoKardia Shares Data from Ongoing Clinical Programs and Details Three New Research Programs at 2018 R&D Day
30/10/2018
Interim PIONEER-OLE Data for Mavacamten Demonstrate Reductions in LVOT Obstruction; Ejection Fraction Maintained above Normal Range First-in-Human Data for MYK-491 in Healthy Volunteers Presented; Phase 2a Multiple- [...]
Resonant to Host Third Quarter 2018 Financial Results Conference Call on Tuesday, November 13th at 1:30 p.m. Pacific Standard Time
30/10/2018
GOLETA, Calif., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ:RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for wireless devices, announced it will [...]
IRADIMED CORPORATION Announces Third Quarter 2018 Financial Results
30/10/2018
Reports third quarter 2018 revenue of $7.6 million Reports third quarter 2018 GAAP diluted EPS of $0.20 and non-GAAP diluted EPS of $0.14 Increases full year 2018 revenue, GAAP and non-GAAP diluted earnings guidance [...]
Rapid Micro Biosystems Announces New Chief Financial Officer
30/10/2018
LOWELL, Mass., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, a leading provider of automated, non-destructive, rapid microbial detection, is pleased to announce the appointment of Sean Wirtjes as Chief [...]
First Patient Enrolled in Anavex Life Sciences Phase 2 Clinical Trial of ANAVEX®2-73 for the Treatment of Parkinson’s Disease Dementia (PDD)
30/10/2018
Study will incorporate genomic precision medicine ANAVEX®2-73-specific biomarkers NEW YORK, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage [...]
Hospital Authority of Hong Kong Selects Mach7 and Client Outlook for Enterprise Imaging Contract
30/10/2018
Enterprise imaging and viewing platforms will support the entire territory of Hong Kong WATERLOO, Ontario, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Mach7 Technologies Limited (Mach7) and Client Outlook, Inc. announced today [...]
Aleafia Labs Partners on Cannabinoid Pharmacogenetics Study
30/10/2018
Study with G420, US-Based AKESOgen aimed at producing genetic tools for improved medical cannabis therapy TORONTO, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Aleafia Labs, a division of Aleafia Health Inc. (TSXV: ALEF: OTCQX: [...]
NeoGenomics Reports 17% Revenue Growth to Record $69 Million
30/10/2018
FT. MYERS, Fla., Oct. 30, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today reported its results for the third quarter of 2018. Third Quarter [...]
Antares Pharma to Report Third Quarter 2018 Financial and Operating Results
30/10/2018
EWING, N.J., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced it will release its third quarter 2018 financial results and recent operating progress before the market opens on [...]
EyePoint Pharmaceuticals Appoints John Landis, Ph.D., M.S., to Board of Directors
30/10/2018
- Seasoned Pharmaceutical R&D and Operations Leader with over 30 Years of Experience - WATERTOWN, Mass., Oct. 30, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals (NASDAQ: EYPT), a specialty biopharmaceutical [...]
Maple Leaf Enters into a Supply Agreement with Cannmart Inc.
30/10/2018
CALGARY, Alberta, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“ Maple Leaf ” or the “ Company ”) ( NEO: MGW, OTCQX: MGWFF ) announces that the Company has entered into a product acquisition agreement [...]
TRU NIAGEN® Recognized as Best Product & Most Popular Brand at Health, Wellness & Beauty Awards 2018 of Watsons Hong Kong
30/10/2018
TRU NIAGEN ® (nicotinamide riboside) receives best product award and recognized as top seller in 2018 amongst Watsons Hong Kong members LOS ANGELES, Oct. 30, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) [...]
Correction to third quarter 2018 financial statements
30/10/2018
Company announcement no. 8-2018 Birkerød, 30 October 2018 ViroGates A/S (Nasdaq First North Denmark: VIRO), announced its financial results for the third quarter 2018 (1 July – 30 September) on 24 October 2018. Certain [...]
Transactions in relation to share buyback program
30/10/2018
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
CorVel Announces Revenues and Earnings
30/10/2018
IRVINE, Calif., Oct. 30, 2018 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) announced the results for the quarter ended September 30, 2018. Revenues for the quarter ended September 30, 2018 were $148 million, an [...]
G1 Therapeutics to Provide Third Quarter 2018 Corporate and Financial Update on November 7, 2018
30/10/2018
RESEARCH TRIANGLE PARK, N.C., Oct. 30, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that it will host a webcast and conference call to provide a [...]
Orion Corporation: Managers' transactions - Konsta Westerlund
30/10/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 30 OCTOBER 2018 at 10.45 EET Orion Corporation: Managers' transactions - Konsta Westerlund Orion Corporation has received the following disclosure under Market Abuse Regulation ( [...]
Verona Pharma to Announce Interim Results for Nine Months Ended September 30, 2018 and Provide Clinical Development Update
30/10/2018
LONDON, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
Clementia Announces Pricing of Public Offering of Common Shares
30/10/2018
MONTREAL, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (Nasdaq: CMTA), a clinical-stage biopharmaceutical company innovating treatments for people with ultra-rare bone disorders and other diseases, [...]

Pages